AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CME GROUP INC. Director's Dealing 2022

Mar 17, 2022

29871_dirs_2022-03-17_042f0188-e312-4e88-977a-9d484064d22f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CME GROUP INC. (CME)
CIK: 0001156375
Period of Report: 2022-03-15

Reporting Person: CRONIN KATHLEEN M (Sr MD Gen Counsel & Corp Secr)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-03-15	Common Stock Class A	A	2542	$232	Acquired	42627	Direct
2022-03-15	Common Stock Class A	F	881	$232	Disposed	41746	Direct
2022-03-15	Common Stock Class A	G	280	—	Disposed	41466	Direct

Footnotes

F1: Represents shares earned from a 2018 performance share award based on the company's achievement of total shareholder return relative to the S&P 500 measured over 2019-2021.

F2: Ms. Cronin surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award.

F3: This transaction involved a gift of securities from the reporting person to a charitable organization.